Related Experiment Video

Updated: Jul 17, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Repression of cyclin D1 as a target for germ cell tumors

Sarah J Freemantle1, Angelina V Vaseva, Katherine E Ewings

  • 1Department of Pharmacology and Toxicology, Dartmouth Medical School, HB 7650, Hanover, NH 03755, USA. sarah.freemantle@dartmouth.edu

International Journal of Oncology
|January 5, 2007
PubMed

Insights

Targeting cyclin D1 offers a new therapeutic strategy for metastatic germ cell tumors (GCTs) that are resistant to chemotherapy. This approach inhibits cancer cell growth and differentiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • Metastatic germ cell tumors (GCTs) are curable, but cisplatin-resistant cases have a poor prognosis.
  • All-trans-retinoic acid (RA) induces G1 cell cycle arrest and cyclin D1 degradation in embryonal carcinoma (EC) cells.
  • Understanding RA's effects on D-type cyclins in resistant GCTs is crucial for developing new treatments.

Purpose of the Study:

  • To investigate D-type cyclins as molecular targets in GCTs.
  • To compare RA's effects on D-type cyclins in sensitive and resistant GCT cell lines and clinical samples.
  • To evaluate the therapeutic potential of targeting cyclin D1 in GCTs.

Main Methods:

  • Utilized human embryonal carcinoma (EC) cell lines (NT2/D1 and RA/cisplatin-resistant NT2/D1-R1).
  • Analyzed D-type cyclin expression (cyclin D1, D3) in response to RA treatment.
  • Employed siRNA to repress specific cyclin D species and assessed cell growth.
  • Used Erlotinib, an EGFR-tyrosine kinase inhibitor, to target cyclin D1 and evaluate proliferation.

Main Results:

  • GCT differentiation correlated with decreased cyclin D1 and increased cyclin D3 expression.
  • RA repressed cyclin D1 transcriptionally and via degradation.
  • siRNA-mediated repression of cyclin D1 inhibited proliferation in both sensitive and resistant EC cells.
  • Erlotinib targeting of cyclin D1 also inhibited proliferation in sensitive and resistant EC cells.

Conclusions:

  • Cyclin D1 is implicated as a key molecular target in GCTs.
  • Targeting cyclin D1, potentially with agents like Erlotinib, shows promise for treating chemoresistant GCTs.
  • This study suggests novel therapeutic strategies for GCT patients with poor prognoses.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...